0.4527
price down icon2.46%   -0.0114
after-market After Hours: .46 0.0073 +1.61%
loading
VolitionRX Ltd stock is traded at $0.4527, with a volume of 724.51K. It is down -2.46% in the last 24 hours and down -31.00% over the past month. VolitionRX Limited, a life sciences company, engages in the development of blood tests to help diagnose a range of cancers worldwide. The company develops 39 epigenetic Nu.Q blood assays based on its Nucleosomics biomarker discovery platform. VolitionRX Limited is based in Singapore.
See More
Previous Close:
$0.4641
Open:
$0.503
24h Volume:
724.51K
Relative Volume:
3.16
Market Cap:
$48.71M
Revenue:
$1.29M
Net Income/Loss:
$-29.87M
P/E Ratio:
-1.2575
EPS:
-0.36
Net Cash Flow:
$-14.70M
1W Performance:
-29.79%
1M Performance:
-31.00%
6M Performance:
-7.23%
1Y Performance:
-34.63%
1-Day Range:
Value
$0.45
$0.503
1-Week Range:
Value
$0.45
$0.67
52-Week Range:
Value
$0.3951
$0.94

VolitionRX Ltd Stock (VNRX) Company Profile

Name
Name
VolitionRX Ltd
Name
Phone
646 650 1351
Name
Address
No. 24-05 Shaw Centre, 1 Scotts Road, Singapore, TX
Name
Employee
37
Name
Twitter
@VolitionRx
Name
Next Earnings Date
2025-08-18
Name
Latest SEC Filings
Name
VNRX's Discussions on Twitter

Compare VNRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
VNRX
VolitionRX Ltd
0.4527 49.94M 1.29M -29.87M -14.70M -0.36
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.58 198.17B 43.21B 6.58B 6.17B 17.28
Diagnostics & Research icon
DHR
Danaher Corp
205.14 144.97B 24.01B 3.41B 4.86B 4.7082
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
633.32 49.29B 4.04B 985.66M 774.34M 12.01
Diagnostics & Research icon
A
Agilent Technologies Inc
138.23 38.73B 6.79B 1.22B 1.09B 4.2644
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
203.77 33.69B 15.70B 1.24B 2.01B 6.9036

VolitionRX Ltd Stock (VNRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-08-25 Initiated H.C. Wainwright Buy
Feb-01-23 Downgrade The Benchmark Company Buy → Hold
Feb-17-22 Resumed Cantor Fitzgerald Overweight
Mar-10-21 Initiated Cantor Fitzgerald Overweight
May-16-18 Initiated Maxim Group Buy
May-14-18 Reiterated The Benchmark Company Buy
Sep-07-16 Reiterated Rodman & Renshaw Buy
Feb-01-16 Initiated Rodman & Renshaw Buy
View All

VolitionRX Ltd Stock (VNRX) Latest News

pulisher
10:58 AM

Published on: 2025-10-13 09:58:07 - newser.com

10:58 AM
pulisher
07:57 AM

Published on: 2025-10-13 06:57:47 - newser.com

07:57 AM
pulisher
02:05 AM

Does VolitionRx Limited show high probability of reboundEntry Point & Free Technical Confirmation Trade Alerts - newser.com

02:05 AM
pulisher
Oct 10, 2025

VolitionRx prices $6 million public offering of common stock and warrants By Investing.com - Investing.com South Africa

Oct 10, 2025
pulisher
Oct 10, 2025

VolitionRx (VNRX) Sets Pricing for Public Offering of Shares and Warrants - GuruFocus

Oct 10, 2025
pulisher
Oct 10, 2025

VolitionRx Prices Public Offering Of 11.55 Mln Shares And Warrants At $0.52/set; Shares Fall - Nasdaq

Oct 10, 2025
pulisher
Oct 10, 2025

VolitionRx Limited Announces Pricing of $6.0 Million Underwritten Public Offering of Common Stock and Common Stock Warrants - Yahoo Finance

Oct 10, 2025
pulisher
Oct 10, 2025

Levi Strauss, USANA Health Sciences And 3 Stocks To Watch Heading Into Friday - Benzinga

Oct 10, 2025
pulisher
Oct 09, 2025

VolitionRx (VNRX) Plans Public Offering to Bolster Development a - GuruFocus

Oct 09, 2025
pulisher
Oct 09, 2025

VolitionRx announces proposed public offering of common stock By Investing.com - Investing.com Australia

Oct 09, 2025
pulisher
Oct 09, 2025

Volitionrx stock tumbles on proposed public offering By Investing.com - Investing.com South Africa

Oct 09, 2025
pulisher
Oct 09, 2025

Volitionrx stock tumbles on proposed public offering - Investing.com India

Oct 09, 2025
pulisher
Oct 09, 2025

VolitionRx announces offering of common stock and warrants, no amount given - TipRanks

Oct 09, 2025
pulisher
Oct 09, 2025

15% Overallotment Option: VolitionRx Proposes Underwritten Offering of Common Stock & Warrants - Stock Titan

Oct 09, 2025
pulisher
Oct 09, 2025

Live market analysis of VolitionRx LimitedJuly 2025 Decliners & Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

VolitionRx Limited Stock Analysis and ForecastPrice Momentum Alerts & Build Diversified Portfolios With Ease - earlytimes.in

Oct 07, 2025
pulisher
Oct 03, 2025

Is VolitionRx Limited a candidate for recovery playFed Meeting & Reliable Price Action Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will a bounce in VolitionRx Limited offer an exit2025 Macro Impact & Real-Time Volume Analysis - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Is VolitionRX Limited stock resilient in recession scenariosJuly 2025 Setups & Weekly High Return Forecasts - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Will VolitionRX Limited stock boost dividends furtherNew Guidance & Accurate Buy Signal Notifications - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Beyond the Genome: Volition Showcases Revolutionary Nu.Q Platform for Epigenetic Drug Discovery - Stock Titan

Oct 02, 2025
pulisher
Oct 01, 2025

VolitionRX (NYSEAMERICAN:VNRX) Trading 9% HigherShould You Buy? - MarketBeat

Oct 01, 2025
pulisher
Sep 30, 2025

H.C. Wainwright reiterates buy rating on VolitionRX stock at $2.50 By Investing.com - Investing.com Australia

Sep 30, 2025
pulisher
Sep 30, 2025

VolitionRX (VNRX) Receives Reiterated Buy Rating by HC Wainwrigh - GuruFocus

Sep 30, 2025
pulisher
Sep 30, 2025

Why analysts remain bullish on VolitionRx Limited stockQuarterly Trade Report & Safe Entry Zone Tips - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

VolitionRx Partners with Hologic to Expand Access to Epigenetic Testing Services for Drug Developers - citybuzz

Sep 29, 2025
pulisher
Sep 29, 2025

VNRX Stock: Analyst Maintains 'Buy' Rating with $5.00 Price Targ - GuruFocus

Sep 29, 2025
pulisher
Sep 29, 2025

What indicators show strength in VolitionRx Limited2025 Volume Leaders & Verified Entry Point Signals - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Can VolitionRX Limited stock sustain free cash flowLayoff News & Stock Timing and Entry Methods - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

$200M Market Opportunity: Volition Teams with $4B Healthcare Giant Hologic for Epigenetic Testing Service - Stock Titan

Sep 29, 2025
pulisher
Sep 26, 2025

What drives VolitionRx Limited stock priceEx-Dividend Date Alerts & Free Popular Stock Picks Selection - earlytimes.in

Sep 26, 2025
pulisher
Sep 25, 2025

Institutional scanner results for VolitionRx LimitedGlobal Markets & Accurate Trade Setup Notifications - newser.com

Sep 25, 2025
pulisher
Sep 24, 2025

News impact scoring models applied to VolitionRx LimitedJuly 2025 Summary & Expert Approved Trade Ideas - newser.com

Sep 24, 2025
pulisher
Sep 23, 2025

Understanding VolitionRx Limited’s price movementWeekly Trade Analysis & Reliable Trade Execution Plans - newser.com

Sep 23, 2025
pulisher
Sep 22, 2025

Using Python tools to backtest VolitionRx Limited strategiesMarket Trend Report & Weekly High Conviction Trade Ideas - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Real time pattern detection on VolitionRx Limited stock2025 Risk Factors & Free Safe Entry Trade Signal Reports - newser.com

Sep 22, 2025
pulisher
Sep 20, 2025

VolitionRX Limited (NYSEAMERICAN:VNRX) Sees Large Growth in Short Interest - MarketBeat

Sep 20, 2025
pulisher
Sep 20, 2025

How to monitor VolitionRx Limited with trend dashboardsIndex Update & Precise Buy Zone Tips - newser.com

Sep 20, 2025
pulisher
Sep 19, 2025

How to use a screener to detect VolitionRx Limited breakoutsJuly 2025 Update & Free Long-Term Investment Growth Plans - newser.com

Sep 19, 2025
pulisher
Sep 19, 2025

Signal strength of VolitionRx Limited stock in tech scannersMarket Growth Summary & Stock Portfolio Risk Control - newser.com

Sep 19, 2025
pulisher
Sep 18, 2025

Bear Alert: What is the long term forecast for VolitionRx Limited stockMarket Rally & Long-Term Growth Plans - khodrobank.com

Sep 18, 2025
pulisher
Sep 18, 2025

Will VolitionRx Limited bounce back from current supportJuly 2025 Recap & Reliable Entry Point Trade Alerts - newser.com

Sep 18, 2025
pulisher
Sep 17, 2025

Aug Breakouts: Whats the MACD signal for VolitionRx Limited2025 Short Interest & Technical Confirmation Alerts - خودرو بانک

Sep 17, 2025
pulisher
Sep 17, 2025

C O R R E C T I O N -- The FUTR Corporation/17.09.25News - Ariva

Sep 17, 2025

VolitionRX Ltd Stock (VNRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

VolitionRX Ltd Stock (VNRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Innes Guy Archibald
Director
Aug 05 '25
Buy
0.64
78,125
50,000
966,814
Reynolds Cameron John
President and CEO
Aug 05 '25
Buy
0.64
78,125
50,000
2,609,847
Reynolds Cameron John
President and CEO
Jun 12 '25
Buy
0.59
12,500
7,372
2,331,722
Innes Guy Archibald
Director
Jun 03 '25
Buy
0.54
20,000
10,772
888,689
Micallef Jacob Vincent
Chief Scientific Officer
May 19 '25
Buy
0.43
50,000
21,500
426,033
Reynolds Cameron John
President and CEO
May 19 '25
Buy
0.44
20,000
8,730
2,319,222
Reynolds Cameron John
President and CEO
Mar 26 '25
Buy
0.55
181,818
100,000
2,299,222
Innes Guy Archibald
Director
Mar 26 '25
Buy
0.55
181,818
100,000
868,689
Innes Guy Archibald
Director
Dec 09 '24
Buy
0.57
174,764
100,000
617,085
STILL TIMOTHY I
Director
Dec 09 '24
Buy
0.57
87,382
50,000
1,487,382
diagnostics_research WAT
$336.33
price up icon 1.61%
diagnostics_research DGX
$182.78
price down icon 0.70%
diagnostics_research LH
$276.64
price down icon 0.45%
$174.17
price up icon 2.89%
diagnostics_research MTD
$1,284.74
price up icon 0.87%
diagnostics_research IQV
$203.77
price up icon 2.83%
Cap:     |  Volume (24h):